Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Omnicom Group’s Merkley + Partners, the creative incumbent on Pfizer’s Lipitor, has been eliminated from the client’s review, leaving three New York shops vying for the estimated $60-80 million account, sources said.
The remaining shops are WPP Group’s JWT, Publicis Groupe’s The Kaplan Thaler Group and mcgarrybowen, an independent, according to sources. The agencies either declined comment or did not return calls.
Merkley, which has handled creative duties on the brand since December 2000, did not return calls.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in